STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin across dose ranges - STELLAR
Study identifier:4522IL/0065
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A 6 week Open Label, Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin versus Atorvastatin, Pravastatin, and Simvastatin in subjects with Hypercholesterolemia.
Medical condition
Hypercholesterolemia
Phase
Phase 3
Healthy volunteers
No
Study drug
Rosuvastatin, Atorvastatin, Pravastatin, Simvastatin
Sex
All
Actual Enrollment
5625
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Apr 2001
Primary Completion Date: -
Study Completion Date: 01 Oct 2004
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 Rosuvastatin | - |
| Active Comparator: 2 Atorvastatin | - |
| Active Comparator: 3 Pravastatin | - |
| Active Comparator: 4 Simvastatin | - |
Contacts
Investigators
Principal Investigator
Eleanor Miller
AstraZeneca
